glp 1 epa Strategies to prevent loss of muscle mass in patients using GLP- ๐client spot light !!!๐ Another
Description
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
Seems logical
Once that muscle percentage hits a certain low point, the body may resist further weight loss to protect itself. While the results needs to be confirmed through more research, especially research in people, the findings highlight a vital need for clinicians to help their patients preserve muscle mass through exercise or nutrition while the patients are on GLP-1s
Anti-apoptotic mechanisms have also been proposed
